Thymic residual masses in adult patients with Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD).

被引：0
|
作者：
Tartas, N
Chacón, C
Domenichini, E
Pascuccelli, H
Sporn, V
Mazzucco, J
Korin, J
Barazzutti, L
Ferro, H
Busso, P
Foncuberta, C
Kusminsky, G
Chacón, R
Avalos, JS
机构：
[1] Alexander Fleming Inst, Buenos Aires, DF, Argentina
[2] CEH, Buenos Aires, DF, Argentina
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4348
引用
收藏
页码：255B / 255B
页数：1
相关论文
共 50 条
  • [31] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Schiepers, Christiaan
    Filmont, Jean-Emmanuel
    Czernin, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S82 - S88
  • [32] Computed tomography (CT), 67Ga SPECT, magnetic resonance (MRI) and histologic findings in residual masses (RM) in patients with Hodgkin's Disease (HD) and Non Hodgkin's Lymphoma (NHL).
    Tartas, N
    Chacón, C
    Domenichini, E
    Pascuccelli, H
    Sporn, V
    Mazzucco, J
    Korin, J
    Kusminsky, G
    Ferro, H
    Orlando, M
    Van Kooten, M
    Foncuberta, C
    Barazzutti, L
    Huertas, E
    Loria, FS
    Chacón, R
    Avalos, JCS
    BLOOD, 1999, 94 (10) : 255B - 255B
  • [33] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [34] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41
  • [35] Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    O'Connor, OA
    Kelly, W
    Wang, ES
    Richon, V
    Moskowitz, C
    Tong, W
    Donnelly, G
    Zelenetz, AD
    Moore, MAS
    Rifkind, RA
    Marks, PA
    BLOOD, 2001, 98 (11) : 611A - 611A
  • [36] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    MODERN PATHOLOGY, 2001, 14 (01) : 180A - 180A
  • [37] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    LABORATORY INVESTIGATION, 2001, 81 (01) : 180A - 180A
  • [38] Does 18F-FDG PET replace bone marrow biopsy (BMB) in patients with Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL)?
    Jerusalem, G
    Silvestre, RM
    Beguin, Y
    Hustinx, R
    Thiry, A
    Fassotte, MF
    Foidart-Willems, J
    Fillet, G
    BLOOD, 2002, 100 (11) : 768A - 768A
  • [39] Anemia associated with non platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)
    Coiffier, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S331 - S331
  • [40] STEM CELL TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA (NHL)
    De Souza, Carmino
    LEUKEMIA RESEARCH, 2017, 61 : S11 - S12
12345